We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmu... Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Annexon's product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; and ANX009, for systemic autoimmune diseases. Show more
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.37 | 8.54503464203 | 4.33 | 4.85 | 4.26 | 1731366 | 4.50710159 | CS |
| 4 | -2.4 | -33.8028169014 | 7.1 | 7.31 | 4.26 | 1549477 | 5.49052489 | CS |
| 12 | 0.53 | 12.7098321343 | 4.17 | 8.4 | 3.86 | 1728722 | 5.8872336 | CS |
| 26 | 2.77 | 143.523316062 | 1.93 | 8.4 | 1.9 | 1258873 | 5.14540691 | CS |
| 52 | -0.83 | -15.0090415913 | 5.53 | 8.4 | 1.57 | 967660 | 4.42928891 | CS |
| 156 | -16.58 | -77.9135338346 | 21.28 | 24.85 | 1.57 | 542888 | 5.83883783 | CS |
| 260 | -12.1635 | -72.1291546832 | 16.8635 | 38.01 | 1.57 | 468528 | 7.31238609 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
